Short Interest in Addus HomeCare Co. (NASDAQ:ADUS) Drops By 6.2%

Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) was the target of a large drop in short interest in November. As of November 30th, there was short interest totalling 425,000 shares, a drop of 6.2% from the November 15th total of 453,200 shares. Based on an average trading volume of 121,500 shares, the days-to-cover ratio is presently 3.5 days.

Insider Transactions at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares of the company's stock, valued at $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO R Dirk Allison sold 12,500 shares of the business's stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now owns 141,897 shares in the company, valued at $17,476,034.52. This represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 4.60% of the company's stock.

Institutional Trading of Addus HomeCare

A number of hedge funds have recently bought and sold shares of the stock. SG Americas Securities LLC acquired a new stake in Addus HomeCare during the second quarter worth about $842,000. Blue Trust Inc. bought a new stake in shares of Addus HomeCare during the second quarter valued at approximately $310,000. Summit Global Investments raised its stake in shares of Addus HomeCare by 7.9% in the second quarter. Summit Global Investments now owns 10,752 shares of the company's stock valued at $1,248,000 after purchasing an additional 790 shares in the last quarter. Louisiana State Employees Retirement System lifted its position in Addus HomeCare by 2.5% in the second quarter. Louisiana State Employees Retirement System now owns 8,100 shares of the company's stock worth $940,000 after purchasing an additional 200 shares during the period. Finally, Argent Capital Management LLC boosted its stake in Addus HomeCare by 51.5% during the second quarter. Argent Capital Management LLC now owns 37,310 shares of the company's stock worth $4,332,000 after buying an additional 12,685 shares in the last quarter. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Price Performance

Shares of ADUS stock traded up $5.41 on Monday, hitting $130.41. The company's stock had a trading volume of 359,171 shares, compared to its average volume of 131,622. The stock has a market capitalization of $2.36 billion, a price-to-earnings ratio of 28.60, a P/E/G ratio of 2.11 and a beta of 1.01. Addus HomeCare has a fifty-two week low of $85.94 and a fifty-two week high of $136.12. The firm's fifty day moving average price is $125.64 and its 200-day moving average price is $124.55.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same quarter in the previous year, the business earned $1.03 EPS. The business's revenue was up 7.1% on a year-over-year basis. Analysts predict that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. JMP Securities assumed coverage on Addus HomeCare in a report on Monday. They issued an "outperform" rating and a $150.00 target price for the company. Royal Bank of Canada reaffirmed an "outperform" rating and set a $136.00 target price on shares of Addus HomeCare in a research note on Thursday, November 14th. Stephens increased their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 6th. KeyCorp assumed coverage on shares of Addus HomeCare in a report on Friday, October 11th. They set an "overweight" rating and a $150.00 price target for the company. Finally, Oppenheimer upped their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a research note on Monday, September 23rd. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $133.67.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.